Back

Asthma and the risk of cardiac events among patients with long QT Syndrome after age 40

27 August 2023 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Ion channel diseases: risk stratification and treatment Risk Factors and Risk Assessment ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Gregory Golovchiner

Rabin Medical Centre, Petah Tikva (Israel)

7 More presentations in this session

Presentation thumbnail
An online international survey study into the incidence and potential reasons of therapy non-adherence in catecholaminergic polymorphic ventricular tachycardia: preliminary results
Mrs P. Peltenburg (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Roles of atrial arrhythmias in triggering torsade de pointes in patients with acquired long QT syndrome
Doctor R. Tochibora (Gifu, JP)
Abstract Slides Video
Presentation thumbnail
Prevalence and prognostic value of epilepsy and Brugada syndrome
Miss E. Rossetto (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Monitoring the electrophysiological effects of hydroquinidine non-invasively in patients with Brugada syndrome
Doctor J. Isbister (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Characterization of the cardiac and non-cardiac phenotype associated with genetic variants in KCNJ2
Doctor D. Abrams (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Ion channel diseases: risk stratification and treatment

The Event

Event poster

ESC Congress 2023

27 August 2023 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Long QT syndrome.
5 April 2022
thumbnail
Congress Presentation
Nationwide insights into QTc prolongation, demographic disparities, and cardiovascular risk factors in Denmark
30 August 2025
thumbnail
Congress Presentation
New risk predictor of arrhythmias in patients with congenital Long-QT Syndrome
27 August 2023
thumbnail
Congress Presentation
Prevalence and characteristics of the catecholamine induced QT prolongation syndrome
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources